Schering Vanceril phase-out
Executive Summary
Schering-Plough completely discontinues Vanceril with phase-out of 42 mcg strength, company says. Vanceril (beclomethasone) 84 mcg was previously discontinued as part of Schering's consent decree with FDA (1"The Pink Sheet" May 27, p. 13). The lower strength of the asthma drug had been on back-order for some time, Schering said. Vanceril generated $82 mil. in sales in 2001...